Egetis Therapeutics
4.96 SEK
-3.79 %
Less than 1K followers
EGTX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.79 %
-19.82 %
-0.40 %
+1.54 %
-29.21 %
-25.71 %
+19.83 %
-12.05 %
-64.19 %
Egetis Therapeutics is a pharmaceutical company focused on developing innovative treatments for rare diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business has a global presence and serves customers worldwide. Egetis Therapeutics was founded in 2006 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
2.1B SEK
Turnover
3.53M SEK
Revenue
46.1M
EBIT %
-714.53 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
29.4
2026
Interim report Q1'26
6.5
2026
General meeting '26
All
Webcasts
Press releases
ShowingAll content types
New publication highlights meaningful clinical benefits of Emcitate® (tiratricol) in treating Resistance to Thyroid Hormone Beta
Members of Egetis' Leadership Team acquire shares in Egetis
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
